A detailed history of Apg Asset Management Us Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Apg Asset Management Us Inc. holds 41,129 shares of ABBV stock, worth $6.79 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
41,129
Previous 558,327 92.63%
Holding current value
$6.79 Million
Previous $95.8 Million 91.52%
% of portfolio
0.06%
Previous 0.55%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $84.7 Million - $103 Million
-517,198 Reduced 92.63%
41,129 $8.12 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $8.24 Million - $9.63 Million
53,265 Added 10.55%
558,327 $95.8 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $25.4 Million - $29 Million
159,037 Added 45.96%
505,062 $92 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $47.6 Million - $53.6 Million
346,025 New
346,025 $53.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Apg Asset Management Us Inc. Portfolio

Follow Apg Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management Us Inc. with notifications on news.